Health Care & Life Sciences » Pharmaceuticals | Collegium Pharmaceutical Inc.

Collegium Pharmaceutical Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
-
-
-
1,711.00
28,476.00
280,413
Cost of Goods Sold (COGS) incl. D&A
169.00
187.00
171.00
868.00
2,595.00
165,677
Gross Income
169.00
187.00
171.00
843.00
25,881.00
114,736
SG&A Expense
15,873.00
17,478.00
26,736.00
94,925.00
99,483.00
135,421
EBIT
16,042.00
17,665.00
26,907.00
94,082.00
73,602.00
20,685
Unusual Expense
79.00
-
91.00
-
1,845.00
-
Interest Expense
76.00
252.00
439.00
94.00
-
20,130
Pretax Income
16,197.00
17,917.00
27,255.00
94,176.00
74,865.00
39,128
Consolidated Net Income
3,958.00
17,917.00
27,255.00
94,176.00
74,865.00
39,128
Net Income
3,958.00
17,917.00
27,255.00
94,176.00
74,865.00
39,128
Net Income After Extraordinaries
3,958.00
17,917.00
59,061.00
94,176.00
74,865.00
39,128
Net Income Available to Common
6,883.00
21,217.00
51,827.00
94,176.00
74,865.00
39,128
EPS (Basic)
2.17
2.84
1.48
3.88
2.47
1.19
Basic Shares Outstanding
7,471.30
7,471.30
13,542.30
24,262.90
30,265.30
32,953.80
EPS (Diluted)
0.92
2.84
1.48
3.88
2.47
1.19
Diluted Shares Outstanding
7,471.30
7,471.30
13,542.30
24,262.90
30,265.30
32,953.80
EBITDA
15,873.00
17,478.00
26,736.00
93,427.00
73,008.00
90,223
Non-Operating Interest Income
-
-
-
-
582.00
1,687
Other After Tax Income (Expense)
12,239.00
-
-
-
-
-
Preferred Dividends
2,925.00
3,300.00
24,572.00
-
-
-

About Collegium Pharmaceutical

View Profile
Address
100 Technology Center Drive
Stoughton Massachusetts 02072
United States
Employees -
Website http://www.collegiumpharma.com
Updated 07/08/2019
Collegium Pharmaceutical, Inc. engages in the development and commercialization of next-generation, abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. Its products include Xtampza ER, and ONSOLIS. Xtampza ER provides pain control while maintaining its extended-release drug release profile after being subjected to common methods of abuse and accidental misuse.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.